Search company, investor...
Xealth company logo


Founded Year



Series B | Alive

Total Raised


Last Raised

$24M | 2 yrs ago

About Xealth

Xealth connects digital health solutions to clinicians and patients. It offers remote patient monitoring, value-based care, patient communication and care gaps, digital therapeutics, virtual care enablement, and more. It was founded in 2017 and is based in Seattle, Washington.

Headquarters Location

506 2nd Avenue Suite 800

Seattle, Washington, 98104,

United States


Xealth's Product Videos

ESPs containing Xealth

The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.

Healthcare & Life Sciences / Health Data & Analytics

The electronic health record (EHR) integrators market is focused on addressing the challenge of fragmented data spread across applications and systems in the healthcare industry. These integrators provide tools to enable healthcare providers to access and share patient data from multiple sources, reducing errors and improving the quality of care. The market is driven by the increasing demand for i…

Xealth named as Leader among 7 other companies, including Redox, 1upHealth, and Huma.AI.

Compete with Xealth?

Ensure that your company and products are accurately represented on our platform.

Xealth's Products & Differentiators

    Xealth Digital Health Platform

    Xealth aggregates and organizes digital health tools and related data within the EHR for easy deployment and oversight. Xealth centralizes vendor integration, distribution and enrollment, and patient monitoring while consolidating reporting and analytics across patient populations and physician groups, driving engagement in digital health. The Xealth platform has three interdependent modules: Digital Care SMART on FHIR app: Digital health is ordered, delivered and monitored from within the EHR. Xealth Digital Command Center: Houses customized reporting and analytics of patient and provider engagement, activation and usage. Xealth Integration Suite: Supports the organization and deployment of multiple solutions through a single set of integrations and clinical rules engine, powering a health system’s digital vendor ecosystem.

Expert Collections containing Xealth

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Xealth is included in 8 Expert Collections, including Conference Exhibitors.


Conference Exhibitors

5,501 items

HLTH is a healthcare event bringing together startups and large companies from pharma, health insurance, business intelligence, and more to discuss the shifting landscape of healthcare


Health Monitoring & Diagnostics

2,623 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance


Digital Health 150

450 items

The winners of the second annual CB Insights Digital Health 150.


Digital Hospital

298 items

Startups recreating how healthcare is delivered


Digital Health

10,338 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.


Health IT

2,650 items

This collection includes public and private companies, as well as startups, that market software solutions to healthcare provider organizations.

Latest Xealth News

Three Reasons Why Strategic Investors Prevail

Apr 18, 2023

| Membership (fee-based) getty When starting Xealth in 2017, we needed to consider our investors. Startups traditionally look to venture capital since VCs are experts in lending money to promising companies and can lend valuable insights that guide their growth. Instead, we focused on strategic investors, believing organizations that could also be our clients and partners are better aligned with our long-term vision than anyone who may be more focused on an exit strategy. This has led us to welcome 15 health systems and additional technology partners as investors. For my team, strategic investors made the most sense with recent events affirming that decision. In addition to 2023 shaping up to be a tight year for VC funding, especially in the digital health industry, we recently witnessed the collapse of Silicon Valley Bank , the nation’s 16th largest bank. More than 2,500 VCs banked with SVB, along with tens of thousands of companies, including Xealth. SVB’s downfall happened so fast that many people were left uncertain when they would access their accounts for business basics, including supplies and payroll. The FDIC covers deposits but only up to $250,000. This led to urgent board calls about short-term concerns. That said, what could have been a scary moment for the company turned into an uplifting show of support as investors, partners and clients came together with offers of assistance—should we need it. Here are three reasons why strategic investors should be considered when seeking funding for your tech startup: 1. They Hold A Unique Understanding Of Your Business MORE FOR YOU These organizations are in your industry. More than advising and seeing pitch decks, they live the challenges and opportunities you outline every day and will know if your value proposition is pie in the sky or legitimate. Strategic investors want you to succeed with your tech startup for business reasons and because they want your vision to come true since it is in line with their own. 2. Diversified Financial Resources Similar to certain social clubs, people with shared interests do business with the same resources, including accountants and banks. VCs are no different. Many of our hospital investors, on the other hand, do not use the same banks as VCs and other startups. This means that we are not all tied to the outcomes of an SVB or another bank. 3. Gaining An Ally Since strategic investors believe in your company and are tied to its success for more than a financial return upon exit through an IPO or acquisition, these organizations are more likely to roll up their sleeves and help when needed. They are able to prepay contracts and settle up invoicing and receivables. Xealth is my sixth startup. Seeing the struggles that some have faced with SVB’s failure—and the outpouring of camaraderie that followed—I am more convinced than ever that strategic investors were the correct path for us at this stage. It has been refreshing to not need the assistance, although comforting to see the support should it be necessary.

Xealth Frequently Asked Questions (FAQ)

  • When was Xealth founded?

    Xealth was founded in 2017.

  • Where is Xealth's headquarters?

    Xealth's headquarters is located at 506 2nd Avenue, Seattle.

  • What is Xealth's latest funding round?

    Xealth's latest funding round is Series B.

  • How much did Xealth raise?

    Xealth raised a total of $54.13M.

  • Who are the investors of Xealth?

    Investors of Xealth include Providence Ventures, UPMC Enterprises, Inception Health, MemorialCare Innovation Fund, Atrium Health and 26 more.

  • Who are Xealth's competitors?

    Competitors of Xealth include Validic and 7 more.

  • What products does Xealth offer?

    Xealth's products include Xealth Digital Health Platform.

  • Who are Xealth's customers?

    Customers of Xealth include Providence, Duke Health, UPMC, Atrium Health and Banner Health.

Compare Xealth to Competitors

1upHealth Logo

1upHealth provides a data aggregation platform. The company uses cloud development tools to enable FHIR (Fast Healthcare Interoperability Resources) APIs to patient data at an individual and population level. It offers quality measures, population health analytics, and healthcare contracts. 1upHealth was founded in 2017 and is based in Boston, Massachusetts. .

Biosceptre International

Biosceptre has identified a pan-cancer target, present in many cancer types, and importantly not found in healthy tissue. Early research and initial evidence suggest that drugs directed at the nf-P2X7 target have the potential to redefine cancer therapy. The Company has raised AUD33m and will be raising further capital through both existing and new investors. Biosceptre has a rigorous, international patent portfolio extending to 2032, providing broad protection of the target and specific protection of antibody products. The Company is developing therapeutics and diagnostics to bind nf-P2X7, with the core of product development in topical and systemic cancer drugs. Biosceptreis also developing an immuno-oncology vaccine, through an existing collaboration, and is in discussions with developmental partners to develop diagnostic and imaging technologies to detect and monitor cancer. Biosceptre is supported by a world-class scientific advisory board, the members of which have been central in the development of numerous, highly successful, biotechnology companies and products. The Company has the team, capital, and plan to create substantial value from this unique, patent-protected, technology. The business is headquartered in Cambridge, UK with additional research facilities in Sydney, Australia.

Health Compiler Logo
Health Compiler

Health Compiler is a developer tool (DevTool) and an application programming interface (API) for accelerating digital health. The company offers integration as a service for healthcare systems, including electronic health records (EHRs) and practice management systems (PMS). It was founded in 2022 and is based in San Francisco, California.

Healthjump Logo

Healthjump provides a cloud-hosted platform for the collection, standardization, and delivery of EHR/EMR data into applications, analytics, clinical research, quality measures reporting, and more without the complex set-up of traditional interface engines. Healthjump was founded in 2013 and is based in King of Prussia, Pennsylvania.

Kyral Health

Kyral Health provides a web3 portal to onboard and transacts with patients, healthcare administrators, insurers, third-party vendors, or any other user of the network. It was founded in 2021 and is based in Chicago, Illinois.


TALON develops software that offers healthcare products and solutions. TALON was formerly known as MyMedicalShopper. The company was founded in 2014 and is based in Portsmouth, New Hampshire.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.